Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mochida Pharmaceutical Co Ltd Raises Mid-year Consolidated Outlook for FY 2014


Friday, 25 Oct 2013 02:00am EDT 

Mochida Pharmaceutical Co Ltd announced that it has raised its mid-year consolidated outlook for revenue from JPY 44,500 million to JPY 45,300 million, operating profit from JPY 6,200 million to JPY 7,900 million, ordinary profit from JPY 6,300 million to JPY 8,000 million, net profit from JPY 3,900 million to JPY 4,400 million, and earnings per share from JPY 191.46 to JPY 216.00, for the fiscal year ending March 2014. The Company raised its mid-year consolidated outlook mainly due to the smooth progress of pharmaceutical related business and postponed expense on research and development. 

Company Quote

6480.0
-10.0 -0.15%
30 Oct 2014